Trials / Unknown
UnknownNCT04135014
Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients
Intranasal Dexmedetomidine or Oral Midazolam Alone Versus Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients Undergoing Minor Surgery
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 138 (estimated)
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
- Sex
- All
- Age
- 2 Years – 6 Years
- Healthy volunteers
- Accepted
Summary
Children tend to anxiety and even fear before survey. And this kind of anxiety will not result in the forced induction of anesthesia, but also may increase the incidence of postoperative agitation in children, even lead to postoperative behavior changes.Currently,Oral midazolam or intranasal dexmedetomidine alone is commonly used as a preoperative regimen, but the clinical effects of each single-use are not satisfactory. In the investigators' study,the researchers conducted the current study to investigate whether dexmedetomidine combined with midazolam can increase the rate of satisfactory anesthesia induction in pediatric patients and achieve better sedative effect.
Detailed description
A trained member of the research team obtained a baseline The Modified Yale Preoperative Anxiety Scale(mYPAS) after obtaining consent. And corresponding study medication is administered about 30-40 minutes before the anesthesia induction.Vital signs were measured every 5 min after study medication administration.The sedation scores of the children were recorded with University of Michigan Sedation Scale (UMSS) every 10 minutes.The onset time of satisfactory sedation and parental separation anxiety scale was noted.Then recorded the degree of cooperation during inhalation anesthesia induction and recovery times.Moreover, recorded the pediatric anesthesia emergence delirium scale (PAED) during the recovery period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Midazolam | oral midazolam 0.5mg.kg-1 approximately 30-40 minutes before surgery using a computer-generated random number table. |
| DRUG | Dexmedetomidine | intranasal dexmedetomidine 2µg.kg-1 approximately 30-40 mins before surgery using a computer-generated random number table. |
| DRUG | Midazolam and Dexmedetomidine | oral midazolam 0.5mg.kg-1 and intranasal dexmedetomidine 1ug.kg-1 approximately 30-40 mins before surgery using a computer-generated random number table. |
Timeline
- Start date
- 2019-10-25
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2019-10-22
- Last updated
- 2019-11-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04135014. Inclusion in this directory is not an endorsement.